COVID-19 Pandemic Requires Global Collaborations
US Pacific Time: May 2, 2020, 5:00pm-7:00pm,
China Beijing Time: May 3, 2020, 8:00am-10:00am
A Dialogue Among Frontline Physicians Battling COVID-19 in China and the United States
- How to prevent mild patients from transitioning into severe patients
- Current COVID-19 epidemiology features
- First-hand clinical experiences from China and US hospitals
- A story of converting an academic lab into a COVID-19 test lab
Please use the following Zoom link to access the webinar:
dial US ：+1 646 558 8656 or +1 669 900 9128 or +1 253 215 8782 or +1 301 715 8592 or +1 312 626 6799 or +1 346 248 7799
Webinar ID： 988 7511 4106Free Registration by clicking here or "Register" button at bottom
Free Registration at Eventbrite, click here to register.
(This event will be broadcast to you through Zoom Conference; agenda is based on US Pacific Time)
5:00pm - 5:05pm Introduction to CABS, Dr. Carrie Wang, President-elect of CABS
5:05pm - 5:10pm Introduction to GLF, Dr. Weixing Chen, President of Gracious Life Foundation
5:10pm - 5:30pm COVID-19 Challenge: Diagnosis and Treatment in Clinic Practice. Dr. Fengming Luo, Professor of Respiratory Therapy, West China Medical School
5:30pm - 5:45pm Epidemiology of COVID-19 Pandemic and Potential Global Collaboration. Dr. Zuo-Feng Zhang, Professor of Epidemiology, UCLA
5:45pm - 6:00pm COVID-19: Challenges in a US ICU. Dr. Michael Bernstein, Pulmonologist, Stamford Hospital Connecticut
6:00pm - 6:15pm How to Setup a Pop-up SARS-CoV-2 Diagnostic Testing Facility at a University without a Medical School in Just Three Weeks? Dr. Lea Witkowsky, Policy Analyst, UC Berkeley
6:15pm - 7:00pm Panel Discussion.
Moderator: Dr. Hua Jiang, Infectious Disease Specialist, Methodist Hospital of Southern California
Panelists: Dr. Fengming Luo, Dr. Zuo-Feng Zhang and Dr. Michael Bernstein, Dr. Lea Witkowsky.
Fengming Luo, MD, PhD
Dr. Fengming Luo is currently the Professor and Dean of Department of Respiratory Therapy, West China Medical School, Sichuan University. He is also the Vice Director, Department of Respiratory and Critical Care Medicine at West China Hospital. Dr. Fengming Luo has been the team lead of medical response team in Wuhan and responsible for 1 ICU and 2 Wards with 98 hospital beds and treated over 300 COVID-19 patients.Dr. Fengming Luo obtained his MD from Chengdu University of Traditional Chinese Medicine, Chengdu, China, MS degree in Medicine from Fujian University of Traditional Chinese Medicine and PhD in Medicine from West China Medical Center, Sichuan University, Chengdu. From 2007 to 2008, he was a Visiting scholar in the Lab of Pulmonary Biolog at Cincinnati Children’s Hospital Medical Center, OH, US.
Zuo-Feng Zhang, MD, PhD
Dr. Zuo-Feng Zhang is a Senior Professor of Epidemiology and Medicine and Associate Dean for Research of the UCLA Fielding School of Public Health. He is also Co-Director of the UCLA AlperCenter for Environment Genomics, and Director of Cancer Molecular Epidemiology Training Program. Dr. Zhang had been a Fellow of the American College of Epidemiology (ACE) and Member of the Board of Directors of the American College of Epidemiology. He was a World Health Organization (WHO) Consultant for National Non-communicable Disease Prevention and Controls in China. He studied preventive medicine and epidemiology in Shanghai Medical University from 1978 to 1987
Hua Jiang, MD
Dr. Hua Jiang is a board-certified Infectious Diseases specialist at the Methodist Hospital of Southern California in Arcadia and Emanate Health (formerly Citrus Valley Medical Center) in Covina, California. A native of Shanghai, he graduated from Shanghai First Medical College (currently Shanghai Medical School, FudanUniversity) in 1983, as one of the top ten graduates in a class of more than 350 students. After graduation, he went on to specialize in Infectious Diseases in Hua Shan Hospital, a premier hospital in China, especially known for its Infectious Diseases program. In 1986, Dr. Jiang came to Harvard Medical School to work at the WHO Collaborative Research Laboratory for Bacterial Resistance Surveillance as a research scholar, studying mechanisms of bacterial resistance to antibiotics. He is current the Chair of Infection Control, Methodist Hospital of Southern California.
Michael Bernstein, MD
Dr. Bernstein is a Co-Clinical Director for the Lung Cancer Screening and Lung Nodule Program at Stamford Hospital with training at Duke University and Mount Sinai Medical Center in New York City. He is also an Assistant Clinical Professor of Medicine in Stamford for Columbia University College of Physicians and Surgeons. Dr. Bernstein has a particular interest and board-certification in interventional pulmonology, a subspecialty within pulmonary medicine focused on bronchoscopy, lung cancer, pleural diseases and other procedures for the lung. Dr. Bernstein is the Associate Director for Pulmonary and Critical Care at Stamford Hospital. A pulmonologist who treats severe Covid patients in Connecticut, where is badly hit by this Covid as part of areas near New York.
Lea Witkowsky, PhD
Dr. Lea Witkowsky is a Policy Analyst at the Innovative Genomics Institute (IGI), a non-profit research partnership between UC Berkeley and UC San Francisco, dedicated to improving and applying genome engineering to solve major world problems. Lea received her PhD from UC Berkeley in 2016, where she studied mechanisms of gene regulation and CRISPR-based gene editing in human cells. She joined the IGI in 2017 to work on engagement, science policy, and social impacts, but has recently pivoted to focus on the IGI’s COVID-19 response. In just three weeks a team at IGI transitioned an academic research lab at a university without a medical center into a CLIA-certified, SARS-CoV-2 clinical diagnostic facility. Lea co-led the effort to document the process in a detailed blueprint for other universities to follow and has led the establishment of policies for the allocation of our testing capacity. When not working on COVID-19, Lea runs an ethics and regulation working group that brings together life scientists, social scientists, lawyers, and ethicists. She aims to inspire and facilitate scientifically informed ethical discussions about genome editing through communications with regulators and policymakers and by convening international events that feature diverse perspectives.
Free registration here and is required to obtain Zoom Conference access link, which will be sent to your registration email before the webinar.
Recommend Using PC/Mac to Register. If CANNOT register using an iPhone, click here.
You can also register free at Eventbrite, click here to register.
Special Thanks to Zoom Video Communications and Beijing Well-being Foundation for technical support.
Free Online Registration – $0 (USD) - 4428 left
Zoom Access Link will be sent to your registration email before the webinar